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Volume 53, Number 17S Abstracts 87Slength, there was no difference in linear elasticity (deforma-
tion 13.3% in tested specimen compared to 12.3% in con-
trol; P0.74). DSC and TMA showed decrease in glass
transition temperature up to 4°C but thermo-tropic tran-
sition was comparable to control.
Conclusions: Simulated physiological in vivo hydrody-
namic fatigue has no significant degradative effect on an
innovative stent-graft from POSS-PCU nanocomposite
polymer. Sutureless technology incorporating nitinol stents
proved to be robust with no separation over accelerated
10-year cycle.
Author Disclosures: M. Ahmed: Nothing to disclose; R.
Bakhshi: Nothing to disclose; A. Darbyshire: Nothing to
disclose; M. Y. Desai: Nothing to disclose; J. Eaton-
Evans: Nothing to disclose; G. Hamilton: Nothing to
disclose; A. M. Seifalian: Nothing to disclose; Z. You:
Nothing to disclose; X. Zhou: Nothing to disclose.
PS222.
Percutaneous Peri-Adventitial Guanethidine Delivery
Induces Renal Artery Sympathectomy: Preclinical Ex-
perience and Implication for Refractory Hypertension
Christopher Owens1, Warren J. Gasper1, Kirk Seward3,
Sanjay Misra4, Stewart B. Jacobson2, Russell M. Jones2.
1University of California San Francisco, San Francisco, CA;
2CVPath, Gaithersburg, MD; 3Mercator MedSystems, San
Leandro, CA; 4Mayo Clinic, Rochester, MN
Objectives: Renal efferent sympathetic nerve overac-
tivity is contributory to the hypertensive state. Guanethi-
dine is known to induce an autonomic denervation through
an immune mediated pathway.We hypothesized that
guanethidine could be safely delivered into the renal peri-
vascular space to produceautonomic denervation and re-
duction in renal norepinephrine (NE) content.
Methods: A micro-infusion catheter (Mercator Med-
Systems) was introduced via the femoral artery into the
renal arteries of (N11) female swin.Two to three ml of
guanethidine (20-30 mg) or vehicle, each with 20% dilu-
tion of contrast, was infused into the adventitial space
under fluoroscopic guidance. The primary efficacy end-
point in this study was kidney NE tissue content measured
by high-performance liquid chromatography.Secondary
outcomes included histological evidence of renal artery
denervation to corroborate efficacy and renal artery injury
and neural inflammation scores.
Results: There were 18 treated renal arteries and 4
vehicle controls in this study.There was 100% procedural
success in the delivery of guanethidine or vehicle to the
renal artery adventitial space.The mean renal artery injury
scores were not different between treated and control pigs
(PNS), and in all cases the endothelial integrity was
maintained.However,in all guanethidine-treated cases
there was histological evidence of peri-neural inflammation
and nerve destruction whereas the nerves appeared normal
in all control animals.There was an overall decrease in renal mortex NE content in a dose dependent fashion, control
4534 ng/g tissue, 20 mg dose 16118 ng/g tissue and
0 mg dose 13316 ng/g tissue, P.038 (Figure).
Conclusions: These data support the hypothesis that
uanethidine can be delivered safely and efficiently into the
enal peri-adventitial space through a novel minimally in-
asive technique.Further, renal NE content is significantly
educed suggesting that this could be a viable procedure in
he treatment of refractory sympathetic-driven hyperten-
ion.
uthor Disclosures: W. J. Gasper: Nothing to disclose;
. B. Jacobson: Nothing to disclose; R. M. Jones: Noth-
ng to disclose; S. Misra: Nothing to disclose; C. Owens:
othing to disclose; K. Seward: Mercator MedSystems,
wnership or PartnershipR43HL102998, Research
rants.
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orcine Mesenchymal Stem Cell Labeling with MRI
ontrast Agent Ferex
ehrnoosh Shahrivar1, Daniel K. Han1, Karen Briley-
aebo2, Andrew Tye1, Michael L. Marin1, Peter L. Faries1.
Division of Vascular Surgery, Department of Surgery,
ount Sinai School of Medicine, New York, NY; 2Depart-
ent of Radiology, Mount Sinai School of Medicine, New
ork, NY
Objectives: Mesenchymal stem cell (MSC) transplan-
ation is currently being investigated in porcine abdominal
ortic aneurysm (AAA) models for its potential as regener-
tive treatment. Reliable methods of labeling and tracking
SCs are necessary to evaluate their effects. This study
ims to evaluate in vitro performance of Ferex, a superpara-
agnectic iron oxide that can be tracked by magnetic
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June Supplement 201188S Abstractsresonance imaging (MRI) and potentially be used for in
vivo labeling of porcine MSCs.
Methods: MSCs were isolated from pig bone marrow
aspirates via Ficoll Paque separation and expanded in cul-
ture. MSCs were incubated with varying concentration of
Ferex and 2 cationic transfecting agents protamine sulfate
and Poly-L-Lysine (PLL). MSCs were then analyzed for
cellular viability, phenotypic preservation and Ferex uptake.
To confirm intracellular Ferex uptake, transmission elec-
tron microscopy (TEM) was performed. AnMRI phantom
was conducted by imaging known numbers of Ferex-la-
beled cells and examining the correlation between resulting
MR signals and cell number.
Results: Ferex uptake was greatest with PLL and 200
ug/ml Ferex (2.7  1.4 pg Fe/cell), with 87.1% cell
viability. Flow cytometry analysis demonstrated that Ferex-
labeled cells maintained phenotypic expression consistent
withMSCs, with positive CD90 signals and negative CD45
and CD117 signals. TEM confirmed that Ferex particles
localized to lysosomes of labeled cells. Phantom studies
demonstrated a strong correlation (R20.9771) between
cell number and in vitro MR signaling values.
Conclusions: As a result, these findings indicate that
Ferex may be used as labeling agent for in vivo tracking of
transplanted MSCs in porcine AAA models.
Author Disclosures: K. Briley-Saebo: Nothing to dis-
close; P. L. Faries: Nothing to disclose; D. K. Han:
Nothing to disclose; M. L. Marin: Nothing to disclose; M.
Shahrivar: Nothing to disclose; A. Tye: Nothing to dis-
close.
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Nitrite Increases Fibroblast Migration and Prolifera-
tion and May Represent a Viable Source of Nitric Oxide
for Wound Healing
Michael Madigan, Fateh Entabi, Guiying Hong, Brian
Zuckerbraun, Edith Tzeng. Surgery, University of Pitts-
burgh, Pittsburgh, PA
Objectives: Nitric oxide (NO) plays an essential role in
wound healing. NO synthase (NOS) knockout mice had
delayed wound closure that was reversed by NOS gene
transfer. Nitrite, an endproduct of NO metabolism, can
serve as a reservoir for NO through conversion by oxi-
doreductases. Thus, we hypothesize that nitrite may be a
source of NO in wound healing.
Methods: NIH3T3 fibroblasts were treated with 1%
serum, 10 nmol PDGF, or increasing levels of nitrite.
Proliferation was measured at 6 hrs with 3H-thymidine.
Cell migration was measured on Boyden Chambers with
PDGF or nitrite in the lower chamber. Giemsa staining was
performed at 4 hrs. Western blot for xanthine oxidoreduc-
tase (XOR), a key oxidoreductase in nitrite conversion, was
performed on cytosol from NIH3T3 cells and healing
mouse wounds. bResults: PDGF increased NIH3T3 proliferation vs. 1%
erum (158%  48). Nitrite increased proliferation in a
ose dependent fashion with a doubling of proliferation at
mM (215% 18, P0.013 vs. PDGF). A similar response
as seen with migration. Ten uM nitrite promoted similar
igration as PDGF (Figure). Western blot showed XOR
xpression in NIH3T3 cells and in the wounds.
Conclusions: Fibroblasts express XOR and can con-
ert nitrite toNO.Nitrite stimulated both proliferation and
igration. Healing wounds also express XOR. Thus, nitrite
ay be a feasible method of NO delivery in wound healing.
he role of nitrite in wound healing in vivo is being
ssessed.
uthor Disclosures: F. Entabi: Nothing to disclose; G.
ong: Nothing to disclose; M. Madigan: Nothing to
isclose; E. Tzeng: Nothing to disclose; B. Zuckerbraun:
othing to disclose.
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PS Induces Angiogenic Behavior in Human Umbili-
al Vein Endothelial Cells In Vitro through Purinergic
ignalling
yan McEnaney, Ulka Sachdev, Xiangdong Cui, Timothy
. Billiar, Edith Tzeng. University of Pittsburgh, Depart-
ent of Surgery, Pittsburgh, PA
Objectives: Purinergic signalling regulates the down-
tream effects of innate immune activation through Toll-
ike receptors (TLRs). We have previously demonstrated
hat innate immune ligands play an important role in an-
iogenesis. Thus, we hypothesize that purinergic signalling
egulates TLR4-mediated angiogenic functions.
Methods: Human umbilical vein endothelial cells
HUVECs) plated onMatrigel-coated wells. The cells were
reated with media alone, LPS 1ug/mL, LPS with nucle-
tide-hydrolyzing enzyme apyrase, or LPS with heat-inac-
ivated apyrase. EC capillary tubule formation was analyzed
ow doses of nitrite induce migration of NIH3T3 cells through a
oyden chamber similar to 10nmol PDGF.y measuring tube length using Metamorph software.
